| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 13 |
| 1 | MIRVETUXIMAB SORAVTANSINE | 10 |
| 2 | CARBOPLATIN | 9 |
| 3 | PACLITAXEL | 7 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 7 |
| 5 | DOXORUBICIN | 6 |
| 6 | GEMCITABINE | 6 |
| 7 | GEMCITABINE HYDROCHLORIDE | 6 |
| 8 | TRABECTEDIN | 6 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIRVETUXIMAB SORAVTANSINE | 10 | 0.0055 |
| 1 | TRABECTEDIN | 6 | 0.0026 |
| 2 | NIRAPARIB | 4 | 0.0002 |
| 3 | DOXORUBICIN HYDROCHLORIDE | 4 | 0.0001 |
| 4 | GEMCITABINE HYDROCHLORIDE | 6 | 0.0001 |
| 5 | BEVACIZUMAB | 13 | 0.0001 |
| 6 | OLAPARIB | 2 | 0.0001 |
| 7 | PREDNISOLONE ACETATE | 1 | 0.0001 |
| 8 | CARBOPLATIN | 9 | 0.0001 |
| 9 | PACLITAXEL | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 13 | 0.0001 |
| 2 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 5 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 6 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |